Andrea B. Smith - 28 Apr 2026 Form 4 Insider Report for HCA Healthcare, Inc. (HCA)

Reporting relationship: Director
Issuer ticker: HCA
Reported as of: 28 Apr 2026
Net transaction value: $0
SEC form: 4
Accepted by SEC: 30 Apr 2026, 17:06:23 UTC
Prior SEC filing: 28 Oct 2025
Next SEC filing: 23 Jun 2026
Source filing: View source filing
Reporting owner signature: /s/ Kevin A. Ball, Attorney-in-Fact

Key filing fact

Andrea B. Smith filed Form 4 for HCA Healthcare, Inc. (HCA) on 30 Apr 2026.

Key facts

This page summarizes Andrea B. Smith's Form 4 filing for HCA Healthcare, Inc. (HCA).
1 reported transaction and 0 derivative rows are listed below.
Accepted by SEC: 30 Apr 2026, 17:06.

Change

Previous filing in this sequence was filed on 28 Oct 2025.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001649634 Primary reporting owner

Smith Andrea B

Relationship: Director
Address: ONE PARK PLAZA, NASHVILLE
Signature: /s/ Kevin A. Ball, Attorney-in-Fact
Signature date: 30 Apr 2026

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

HCA transaction

Common Stock

Award

Transaction value
Shares: +509
Change %: +12%
Price: $0.000000^*
Shares after: 4,666
Date: 28 Apr 2026
Ownership: Direct
Footnotes: F1

HCA holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after: 82
Date: 28 Apr 2026
Ownership: By managed accounts
Footnotes: F2

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 2 footnotes

Footnote F1

Represents common stock underlying 509 restricted share units attributable to an annual director equity award, which shall vest on the sooner of the date of the Issuer's 2027 annual shareholders' meeting or the first anniversary of the grant date. Vested shares will be delivered to the reporting person on the date the reporting person ceases to be a member of the Board of Directors of the Issuer.

Footnote F2

The shares reported herein are held in fully managed accounts over which the Reporting Person does not have any investment authority. The Reporting Person disclaims beneficial ownership of the shares reported herein except to the extent of her pecuniary interest therein.